Pharmaceutical The global cancer vaccines market in seven key markets (the USA, France, Germany, Italy, Spain, UK and Japan) was worth $3.48 billion in 2010, after increasing at a compound annual growth rate (CAGR) of 63.7% during 2006-2010, notes a new report from GlobalData. Over the 2010-2018 period, the market is expected to record a CAGR of 12.7%, to reach $9.08 billion by 2018. This high growth is attributed to the increasing patient population of cancer. 24 October 2011